Malaria P.f/P.v Antigen Rapid Test
Malaria P.f/P.v Antigen Rapid Test
Product Introduction
The Malaria P.f/P.v Antigen Rapid Test is a high-performance lateral flow chromatographic immunoassay designed for the qualitative detection and differentiation of Plasmodium falciparum (P.f) and Plasmodium vivax (P.v) antigens in human whole blood specimens.
This dual-antigen rapid test simultaneously identifies the two most prevalent and clinically significant malaria species — P. falciparum and P. vivax — from a single blood sample. By providing clear, species-specific results in just 15 minutes, the test enables healthcare professionals to make fast and accurate diagnostic decisions, facilitating timely treatment and effective patient management.
Key Features and Benefits
- Dual Species Differentiation: Simultaneously detects P.f-specific HRP2 antigen and P.v-specific pLDH antigen, allowing clear distinction between Plasmodium falciparum and Plasmodium vivax infections.
- Rapid Results: Delivers easy-to-read results within 15 minutes, significantly reducing diagnosis time compared to traditional microscopy.
- High Accuracy: Optimized for sensitive detection of both P.f and P.v, supporting reliable screening even in low-parasite-density cases.
- Simple & Convenient: Requires only a small volume of whole blood (fingerstick or venous), with no need for laboratory equipment or complex procedures.
- Ideal for Point-of-Care Use: Perfect for hospitals, clinics, mobile health units, and resource-limited or endemic areas where rapid on-site testing is essential.
- Professional Screening Tool: Serves as an effective aid in the diagnosis of malaria, helping clinicians triage patients quickly and initiate species-specific treatment.
Intended Use
The Malaria P.f/P.v Antigen Rapid Test is a lateral flow immunoassay intended for the qualitative detection and differentiation of Plasmodium falciparum (P.f) and Plasmodium vivax (P.v) antigens in human whole blood specimens.
It is designed for professional use as an aid in the diagnosis of malaria infection. All reactive results should be interpreted in conjunction with clinical symptoms and confirmed by supplemental diagnostic methods such as microscopy or molecular testing.
For In Vitro Diagnostic (IVD) use only.
Why Choose This Test?
In malaria-endemic regions and travel medicine settings, rapid and accurate species identification is critical. P. falciparum can cause severe and life-threatening complications, while P. vivax is known for its ability to cause relapsing infections. The Malaria P.f/P.v Antigen Rapid Test provides a fast, reliable, and cost-effective solution to differentiate these two major species, supporting better treatment decisions, improved patient outcomes, and more effective malaria control efforts.
This easy-to-use combo test is an essential tool for healthcare providers seeking efficient malaria screening and targeted therapy in both high-burden and resource-limited environments.
FAQs:
1. What is a Malaria P.f/P.v Antigen Rapid Test?
It is a lateral flow chromatographic immunoassay designed for the simultaneous detection and differentiation of Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) antigens in human blood.
2. How does the P.f/P.v test differentiate between malaria species?
The test uses specific antibodies to capture unique antigens—typically HRP2 for P. falciparum and pLDH specific to P. vivax—on separate test lines.
3. Why is it important to distinguish between P. falciparum and P. vivax?
Differentiation is critical because P. falciparum can cause severe, life-threatening malaria, while P. vivax requires specific treatment to prevent relapses from dormant liver stages.
4. What specimen type is required for this malaria rapid test?
The test is performed using human blood specimens, which can be collected via finger-prick capillary blood or venous whole blood.
5. How long does it take to get results from the Pf/Pv combo test?
This rapid diagnostic kit provides clear, qualitative results within 15 to 20 minutes, enabling immediate clinical assessment.
6. Is this malaria antigen test intended for professional use?
Yes, it is strictly intended for professional use by healthcare providers in clinics, hospitals, and laboratory settings.
7. Does a reactive result require further confirmation?
Yes, any reactive specimen must be confirmed with alternative testing methods, such as microscopic examination of a blood smear, and integrated with clinical findings.
8. What is the primary technology used in this diagnostic kit?
It utilizes Lateral Flow Immunoassay (LFIA) technology, a proven method for rapid, equipment-free antigen detection.
9. Can this test be used for point-of-care (POC) testing?
Absolutely. Its simple procedure and fast turnaround time make it ideal for POC testing in resource-limited or field environments.
10. Does the kit require any specialized laboratory instrumentation?
No, this is a self-contained test cassette that allows for visual interpretation of results without the need for extra equipment.
11.What is the significance of the "Control (C)" line on the cassette?
The Control line indicates that the liquid has flowed correctly and the test procedure was performed properly; it must always appear for a valid result.
12. Is the Malaria Pf/Pv Ag Test Kit used for initial screening?
Yes, it serves as an efficient frontline screening tool to identify malaria-infected individuals quickly during an outbreak or clinical visit.
13. How should these rapid test kits be stored?
Kits should be stored in their original sealed packaging at temperatures specified by the manufacturer (usually 2–30°C) to ensure shelf-life stability.
14. What are the common symptoms that warrant a malaria test?
Patients presenting with fever, chills, headache, and flu-like symptoms in malaria-endemic areas should be screened using a rapid diagnostic test.
15. What is the clinical role of this test in tropical medicine?
It plays a vital role in reducing malaria mortality by facilitating early diagnosis and ensuring patients receive the correct species-specific treatment.












